Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function.
about
Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transferGlycosphingolipid-Protein Interaction in Signal TransductionCeramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitisConsequences of beta-glucocerebrosidase deficiency in epidermis. Ultrastructure and permeability barrier alterations in Gaucher diseaseABCA12 maintains the epidermal lipid permeability barrier by facilitating formation of ceramide linoleic estersDetection of trace glucose on the surface of a semipermeable membrane using a fluorescently labeled glucose-binding protein: a promising approach to noninvasive glucose monitoring.Sphingolipid activator proteins are required for epidermal permeability barrier formation.Accumulation of protein-bound epidermal glucosylceramides in beta-glucocerebrosidase deficient type 2 Gaucher mice.Slow internal release of bioactive compounds under the effect of skin enzymes.Imaging mass spectrometry visualizes ceramides and the pathogenesis of dorfman-chanarin syndrome due to ceramide metabolic abnormality in the skinNon-pseudogene-derived complex acid beta-glucosidase mutations causing mild type 1 and severe type 2 gaucher disease.Glucosylceramides stimulate murine epidermal hyperproliferation.Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis.Topical hesperidin prevents glucocorticoid-induced abnormalities in epidermal barrier function in murine skin.Focal adhesion kinase controls pH-dependent epidermal barrier homeostasis by regulating actin-directed Na+/H+ exchanger 1 plasma membrane localization.Is the filaggrin-histidine-urocanic acid pathway essential for stratum corneum acidification?sPLA2 and the epidermal barrier.Topical peroxisome proliferator activated receptor activators accelerate postnatal stratum corneum acidification.Performance of transdermal therapeutic systems: Effects of biological factorsAcute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2Epidermal sphingolipids: metabolism, function, and roles in skin disorders.Epidermal barrier: Adverse and beneficial changes induced by ultraviolet B irradiation depending on the exposure dose and time (Review)Activators of the nuclear hormone receptors PPARalpha and FXR accelerate the development of the fetal epidermal permeability barrier.Three-dimensional skin models as tools for transdermal drug delivery: challenges and limitations.Fat in the skin: Triacylglycerol metabolism in keratinocytes and its role in the development of neutral lipid storage disease.Acidification in the epidermis and the role of secretory phospholipases.The stratum corneum: the rampart of the mammalian body.'Memory' of the stratum corneum: exploration of the epidermis' past.Hyaluronan tetrasaccharides stimulate ceramide production through upregulated mRNA expression of ceramide synthesis-associated enzymes.Advancements in the maintenance of skin barrier/skin lipid composition and the involvement of metabolic enzymes.Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier.Permeability Barrier and Microstructure of Skin Lipid Membrane Models of Impaired Glucosylceramide Processing.The stratum corneum revisited.Morphology of lipid alterations in the epidermis: a review.Regulation of glycosphingolipid metabolism in liver during the acute phase response.Activation of bacterial ceramidase by anionic glycerophospholipids: possible involvement in ceramide hydrolysis on atopic skin by Pseudomonas ceramidase.Tight junction properties change during epidermis development.Localization of sphingomyelin during the development of dorsal and tail epidermis of mice.Passive Diffusion of Transdermal Glucose: Noninvasive Glucose Sensing Using a Fluorescent Glucose Binding Protein.Increased expression of aquaporin-3 in the epidermis of DHCR24 knockout mice.
P2860
Q24307584-7CC6962E-14D4-4454-8278-6C5AB08E4313Q28072827-F2D918F4-7A87-4675-85D1-63A8814A1900Q28369477-75EF47DA-5A34-4F40-B7CC-FD5404564D3CQ28369639-366FCD8F-B52A-4533-91F1-F5B84FAC3B11Q28511467-93EBBB78-1B3A-4827-B32E-AA4053711690Q30445129-2F7415E4-8643-4BEA-91F8-EFE6A81EC98CQ30668998-EC8C1326-648D-4197-9D65-1C2E58720D64Q30673583-CEF7D439-C6B6-4A82-8502-9E08A3B587BCQ33221670-69AF7E62-9EF9-4508-AD20-B5AEDD75915FQ33456373-D40A8EA4-B1AA-4EBB-918C-3A6826071D0FQ33844209-3E2232EE-2755-43B8-98C9-3A9FB2615AF9Q34224502-F539B0EF-7714-4B79-B7CE-5C1C814B5644Q34687966-1CABDC31-D376-41B9-8980-A7B5B47C6EA5Q35843367-E75AB85D-0652-409B-9232-61C3F7B8B3B1Q35855529-A8036E56-2920-43C6-9F8A-7F0DADB6CBEFQ35994820-55B0BA83-7698-4459-9679-0DE5A45B1E68Q35994859-1178DDC9-018C-453D-8AE2-6BA1398BF477Q35994887-97229C2D-F725-4B66-B287-20275DC69C18Q36300173-75DB8FCE-289E-4CB4-B943-3E68DB2C0388Q36357354-ECB124E1-703D-480B-A9BE-3D9C138039B7Q36589543-E163A9A9-7437-4280-81F3-FA27067D4DC0Q37207339-7A3242CC-8257-45B5-908E-E1121BB5C009Q37370780-E807639D-B804-4C74-A5DF-7690776CB048Q37859027-B73029F1-1E77-4534-9FED-5695364F68D7Q37892924-A308026B-55FC-4991-AD4B-0F55A08CAE48Q37892926-9694E160-46A7-443B-9076-15F4D09081D9Q38075148-5A74CAB6-C9F1-46ED-8914-D8AB0398B427Q38252382-2A410C8A-038E-45F9-9D61-0D8DA2E59CB5Q38808394-370DE992-C6D5-43C4-AC94-600DB401EF13Q38894252-AD48D7AD-7A07-43E2-92C8-0A8CA064FD28Q40857896-69AF2DC8-DAE3-4286-B346-814A5A8B4F03Q41125645-34128938-AB19-407C-B29B-4519953C9FB2Q41303652-487DBB75-E4F9-4D8E-9AF6-4CD36B268E7CQ41465321-67E11FF9-57CA-47F9-AB03-5F7B898EA7CAQ41676991-7B33B1E2-6F8B-40B2-867B-030780350CFCQ41782077-E3F33AC4-B67D-412E-8F33-D9C6DDFB2550Q42411338-C0A6B6DE-31DA-4DCF-95C6-CFB819E28004Q42513847-BD6DB768-EC82-45F2-9921-D7D0F15ED1C8Q42723832-7E70C434-9C78-4A73-BCCB-EB948448FC70Q46778139-C181AFEB-AC45-4DC9-99E4-0F153DB3FDD9
P2860
Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function.
description
1993 nî lūn-bûn
@nan
1993 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Processing of epidermal glucos ...... permeability barrier function.
@ast
Processing of epidermal glucos ...... permeability barrier function.
@en
type
label
Processing of epidermal glucos ...... permeability barrier function.
@ast
Processing of epidermal glucos ...... permeability barrier function.
@en
prefLabel
Processing of epidermal glucos ...... permeability barrier function.
@ast
Processing of epidermal glucos ...... permeability barrier function.
@en
P2093
P2860
P356
P1476
Processing of epidermal glucos ...... permeability barrier function.
@en
P2093
P2860
P304
P356
10.1172/JCI116374
P407
P577
1993-04-01T00:00:00Z